BACKGROUND: Digital pathology increasingly has been gaining the attention of pathologists worldwide. However, the application of digital cytology by Panoptiq (ViewsIQ, Vancouver, Canada) microscope-based scanning software is relatively unexplored. Panoptiq enables the operator to combine low-power panoramic digital images with z-stacks at regions of interest with a significantly smaller image size than that obtained by whole-slide scanning. The current study aimed to evaluate the feasibility of the use of Panoptiq in the digital interpretation of cervicovaginal cytology specimens in comparison with conventional light microscopy. METHODS: A total of 100 liquid-based cytology slides were selected sequentially. The dotted slides were reviewed and scanned, in which all dotted areas were scanned further by the 320 objective with z-stacks. The cases were reviewed by 4 pathologists and a cytotechnologist using conventional light microscopy and 
INTRODUCTION
Pathology laboratories worldwide have the increasing possibility to scan histology slides digitally. However, scanning cytology samples remains a cumbersome activity. The process is negatively influenced by factors such as length of time, data storage, and diagnostic performance. 1 Although many whole-slide image scanners allow for cytological specimens to be scanned semiautomatically, the restrictively high cost caused by scanning cytological specimens with the z-stack acquisition and facilitating data storage remains a high hurdle. Furthermore, for smaller laboratories, it is difficult to justify low-throughput or ad hoc applications. The Panoptiq digital imaging platform works with most microscopes that can accommodate a mounted digital camera. While an individual examines a glass slide with the microscope, Panoptiq software digitally stitches together multiple fields of view into a single SVS file in real time. 2 The system also is capable of digitizing slides at multiple magnifications and focus planes. In contrast, to the best of our knowledge, all other commercially available slide scanners do not allow for simultaneous scanning and screening to enhance the cytology workflow. The Panoptiq system has been used successfully for various clinical applications such as imaging frozen tissue sections, microbiology slides, and peripheral blood smears. 3, 4 To our knowledge, this technology has been evaluated for cytopathology once previously by Hanna et al. 5 In the current study, we evaluated the possibility of diagnosing cervicovaginal cytology with the digital Panoptiq imaging system. The main objective of this study was to determine the feasibility of digital cytology compared with conventional light microscopy for diagnostic readings made on cervicovaginal liquid-based cytology specimens.
MATERIALS AND METHODS
The institutional review board of the study institution approved this retrospective investigation (protocol 16103103). A total of 100 BD SurePath Papanicolaou tests (Becton, Dickinson and Company, Franklin Lakes, New Jersey) were sequentially selected out of achieved material at the Kameda General Hospital. Cases were collected from December 1, 2016, until January 31, 2017. In the current study, we digitized 100 liquid-based cytology routinely dotted samples using the Panoptiq digital imaging software platform. The dots of all slides were maintained but reviewed and checked for sample adequacy by an experienced cytotechnologist at Nagasaki University Hospital. All personal identifiers on the glass slides were censored.
Image Acquisition
A Blackfly digital camera (model BFLY-U3-23S6C; Point Grey Research, Richmond, British Columbia, Canada) was mounted on an Olympus U-TV1XC c-mount (Olympus Corporation of the Americas, Center Valley, Pennsylvania). This set then was attached to the top of an Olympus BX57 microscope with an UPlanSApo revolver (Olympus Corporation of the Americas) holding the 34 (0.16), 310 (0.4), 320 (0.75), and 340 (0.95) objectives. Panoptiq (version 4.0.1) was used to scan each slide and the diagnosis was made by reading images displayed using the application Panoptiq View (version 4.0.1) (364 bit) on an Data I/O 4K LCD-M4K282XB 28' monitor (Data I/O Corporation, Redmond, Washington) with the resolution set to 2560 3 1440 (DisplayPort, HDMI). Calibration profiles were created according to each objective's individual numerical aperture and exposure time using an ordinary blank glass calibration slide. The 34 objective was used to create digital maps in which dotted areas after were focally scanned or z-stack volumes were embedded with the 320 objective. The slides were scanned by another cytotechnologist who received iterative training on the image scanning, and the regions of interest were selected according to the dotted areas. For the Panoptiq digital imaging software, the recording time started when the cytotechnologist pressed the start scan button and finished once the SVS file was saved. After completing the scans, the quality and completeness of the image data were checked by the cytotechnologist who reviewed the slide.
Observers
Four board-certified pathologists with > 30 years of experience and 1 board-certified cytotechnologist rendered their cytological diagnosis using Panoptiq View (version 4.0.1). The observers made a judgment based on The Bethesda System. The observers had the option to omit cases suspected for incompleteness of the scanned image or out-of-focus areas, or due to image quality. A washout time of 3 weeks for each observer was set to reduce the reviewers' bias (Fig. 1) .
Data Analysis
The Cohen kappa coefficient was calculated to measure intermodality agreement between conventional light microscopy and Panoptiq, and the interobserver agreement was calculated for the participating observers for each modality: 0 indicated no agreement, 0.01 to 0.20 indicated slight agreement, 0.21 to 0.40 indicated fair agreement, 0.41 to 0.60 indicated moderate agreement, 0.61 to 0.80 indicated substantial agreement, and 0.81 to 1.00 indicated nearly perfect agreement. Discrepant intermodality observations were divided into minor and major discrepancies. An example of a minor discrepancy was a cytological diagnosis of atypical squamous cells of undetermined significance (ASCUS) and a cytological diagnosis of lowgrade squamous intraepithelial lesion (LSIL) affecting recommended follow-up time. We defined a major discrepancy as a cytological misinterpretation of LSIL versus high-grade squamous intraepithelial lesion (HSIL), which negatively affected clinical treatment because HSIL cases require colposcopic evaluation and a cervical conization. Generally, cases that are positive for HSIL also are more likely to be associated with a persistent human papillomavirus infection and have a higher risk of progressing to cervical cancer. [6] [7] [8] Finally, all participants were asked to complete a questionnaire, using a rating scale from 1 to 5, of their ability to measure image quality, overall diagnostic confidence, and user experience. A digital case analysis was performed by calculating the average data storage, scanning time, and the number of 320 focal scans and number of 320 embedded volumes. The statistical analysis was performed using JMP statistical software licensed by Nagasaki University.
RESULTS

Digital Cytology Case Analysis
Of the 100 cases scanned, 4 contained corrupted data caused by z-stacks that were not fully embedded on the main scan and therefore these cases were excluded from further analysis. The average data size per case of the 96 cases was 226 megabytes (range, 64.4-483.4 megabytes), the average number of focal 320 scans per case was 4.2 (range, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] , and the mean number of embedded z-stacks per case was 6.15 (range, 0-14). The average image 
Intermodality Agreement
We calculated the concordance rate and intermodality agreement: pathologist A had a kappa of 0.84, pathologist B had a kappa of 0.41, pathologist C had a kappa of 0.76, pathologist D had a kappa of 0.44, and the kappa for the cytotechnologist was 0.86 (Table 1 ). The most common mismatches noted in all data were between ASCUS/atypical squamous cells, cannot rule out high-grade squamous intraepithelial lesion (ASC-H) and LSIL, which may indicate poor reproducibility of the recognition of koilocytosis or koilocytotic atypia, followed by the discrepancy between LSIL and HSIL, suggesting difficulty in recognition of varying levels of cellular atypia. 9 Among the other observers, pathologist B demonstrated a trend toward reduced recognition in the presence of both koilocytosis and cellular atypia in Panoptiq compared with conventional microscopic observations ( Table 2 ). The results from pathologists A, C, and D and the cytotechnologist are listed in Supporting Information Tables 1, 2 , 3, and 4.
Interobserver Agreement
There was a fair diagnostic agreement (kappa of 0.17-0.41) between the 5 blinded observers when using conventional light microscopy only (Table 3) . Similar results have been observed in other studies. [10] [11] [12] [13] When using digital pathology, the 5 blinded observers achieved a moderate/substantial agreement (kappa of 0.22-0.72) ( Table 4 ), indicating that digital cytology may increase the overall standardization of cervicovaginal cytology. 
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Evaluatory Questionnaire
The overall experience of the observers was satisfactory. Two observers reported that the image quality of Panoptiq was equivalent to that of glass slides but that the digital cytology image allowed for a more wide observation than light microscopy because of the digitally enlarged cytomorphology seen on the monitor. For example, in one case, cellular changes compatible with a herpes simplex infection were missed by microscopic examination (Fig. 2) . Pathologist A mentioned that the time to formulate a diagnosis Table 5 .
DISCUSSION
Feasibility and Future of Digital Cytology
Current commercially available scanners are likely to produce cytology images with unfocused areas, a lengthy waiting time, and excessively large data per file (containing up to 1-15 gigabytes in size). Thus, scanning devices themselves are hefty and often beyond the budget of small community laboratories. The unique digital cytology solution offered by ViewsIQ (Richmond, British Columbia, Canada) comes with a high frame rate charge-coupled device (CCD) camera capable of producing high-quality images and can be mounted easily on any microscope using either the c-mount or an ocular route. The scanning process is user-driven and the image acquisition can be performed parallel to cervical cancer screening, thereby functioning as a quality check for cytotechnologists ensuring that all areas of the cytological specimen are observed. Panoptiq creates interesting opportunities to facilitate consultation services, rapid on-site evaluation of fine-needle aspiration specimens, tumor boards, workshops for pathology residents, and better morphologic comparison between Papanicolaou tests and cervical biopsies for continuing medical education. 14, 15 To the best of our knowledge, Panoptiq does not yet have an option for automation, which would limit its use in high-throughput laboratories. The future of pathology will depend more and more on the use of image analysis, such as tumor recognition algorithms and quantitative immunocytochemical analysis for personalized medicine. 16 The fair interobserver variation noted in the current study serves as a representative example. The development of a robust digital device for cytology is critical for the advancement of the field.
17,18
Experience in Digital Readings Matters for Intermodality Variation
According to the results of the evaluatory questionnaire, pathologists A and C and the cytotechnologist had more previous user experience with viewing digital slides. Pathologist A had been reviewing scanned slides for approximately 6 months, whereas pathologist B had been doing so for only a month. It is fair to speculate that this might have negatively affected the intermodality agreement for pathologists B and D. Pathologist B had the least exposure to digital pathology among all observers and demonstrated a much lower agreement between microscopic observation and Panoptiq. These results indicate that the observers' years of experience in microscopic observations do not matter but that the observers' experience in digital modality might affect the interpretation.
Analysis of Discrepant Cases
In the current study, microscopic observations were interpreted as the gold standard. Therefore, we extracted the minor and major intermodality discordant cases of pathologist B, in which the diagnosis of Panoptiq was upgraded in microscopy. We hypothesized either that the current digital cytology modality affects the overall interpretation of morphology viewed on the screen, the results were due to a lack of observational skills, or that the scanning process itself might cause a new preselection bias of the dots themselves. Seven cases were underdiagnosed by pathologist B from LSIL to HSIL and 1 case was overdiagnosed as HSIL by conventional microscopy and as LSIL on the Panoptiq system. Eleven cases were underdiagnosed from ASCUS to LSIL and 5 cases were overdiagnosed as ASCUS by conventional microscopy and LSIL on the Panoptiq system. The 7 underdiagnosed cases were considered to be major discordant cases and underwent a complete review by the other observers involved in the current study (Table 6) . A consensus was reached for one major discrepancy case in which the dots appeared to be ineffective, resulting in a downgrade from HSIL to LSIL through the digital modality (Fig. 3) . The other 6 cases were considered through group consensus to be misjudged due to the interpretive skills of pathologist B.
Limitations of the Current Study
The Panoptiq imaging system, as well as the design of the current study, have limitations in adequately measuring the effectiveness of the overall application. First, image acquisition using Panoptiq makes use of the skills of trained cytotechnologists to scan regions of interest that the cytotechnologist presumes to be accurately representing the lesion of interest. This may cause selection bias and raises concerns with most pathologists, mainly for not being able to view unmarked areas at a magnification of 320. Second, if a pathologist disagrees with the selected scan area, easily adding new areas is not possible. In that case, the entire slide needs to be rescanned. Third, in the current study, we did not compare the initial screening by Panoptiq versus routine microscopic screening without dots. This should be considered as a next step in validating the system. Fourth, training of the observers was not enforced. However, a user protocol was distributed before observations were made. Fifth, the numbers of cases and observers were relatively small and limited to the cervicovaginal cytology subspecialty, and therefore future studies should include clinicians from different subspecialties or enrichment of the study set with challenging cytology cases. 19 
Conclusions
The results of the current study demonstrate that cervicovaginal cytology specimens can be easily scanned by the Panoptiq imaging system using the ordinary UPlanSApo 34 and 320 objectives, with diagnostic intermodality kappa values comparable to those of conventional light microscopy, and that liquid-based cytologic preparations can be scanned in <5 minutes with an average data size, not exceeding 500 megabytes per slide. The need for continuous quality control steps is important. Therefore, the cytotechnologist or digital pathology technician needs to be well aware of the method of image acquisition, which could induce a selection bias. Observer experience in digital modalities also is a risk factor because the lack of experience could lead to an erroneous outcome. In addition, the establishment of laboratory scanning and training protocols for digital cytology is strongly advised.
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